|
2. ROLANDO N; FIGUEROA R; TAKANO J y col Estudio clínico, Bioquímico y anatomopatológico de los portadores de Antígeno de Superficie de la Hepatitis (HBsAg) en Abancay. Rev Gastroenterol Perú, 1983 - 1: 22-32.
3. COLICHÓN, A; VILDÓSOLA H, SJOGREN M; et al Respuesta serológica a una vacuna DNA recombinante en nativos residentes de dos areas Hiperendémicas hepatitis B en la Amazonía Peruana. Rev Gastroenterol Perú, 1993; 13: 78-84
4. CABEZAS CESAR; GOTUZZO EDUARDO; ESCAMILLA JOEL; PHILLIPS IRVING. Prevalencia de Marcadores serológicos de hepatitis Viral A, B, Y Delta en escolares aparentemente sanos de Huanta (Perú). Rev Gastroenterol Perú, 1994; 14: 123-134.
5. INDACOCHEA S, GOTUZZO E. Mortalidad por Hepatitis Viral B en Abancay Rev Gastroenterol Perú,1993; 13; 173 – 177.
6. GELLISEN G, WEYDEMANN U, STRASSER A. W M et al. Progress in developing methyltrophic yeast as expression systems. Tibtech 1992; 10: 413-417.
7. GROP PJ; JAIG W, MILME A et al Unresolved issues in hepatitis B immunization in viral hepatitis and liver diseases (Ed: Hollinger FB, Lemon SM, Morgolic II) Williams and Wilkins. Baltimore USA 1991 pg 856-860.
8. GELLISEN G. Hansenula Polymorpha: Biology and applications. Chapter 12 Recombinant hepatitis B vaccines- diseases characterization and vaccine production 2002: 175-200.
9. EYIGUN CP, YILMAZ S, GUL C, SENGUL A, Hacibektasoglu A, Van Thiel DH. et al. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
J Viral Hepat. 1998 Jul; 5(4):265-9.
10. KANG, J KIM, Y. KIM K. Immunogenicity and Safety of HB vaccine derived by test. The Korean J Intern Med 1986; 31,318-322.
11. BUCKHOLZ, R.G., GLEESON M.A. Biol Technology, 1991; 9;1067-1072.
12. ABRAHAM P. NANDWANIL S, SRIVASTAVA A.K. Timmermans I.T.F. Immunogenicity and safety of Hepavax-Gene recombinant Hepatitis B vaccine in healthy adolescents between the ages of 15 to 19 years. 10th ICID March 2002; Singapore 11-14.
13. P. ABRAHAM, TS NARAYANAN, FP Mistry - Safety and Immunogenicity of an r-DNA Hepatitis B Vaccine (Hepavax-gene) in Healthy Indian Adults - JAPI, (2000) - Vol 48.
14. ZAPATA F R. Hepatitis B: Inmunogenicidad de la vacuna. Hepavax-Gene en Trabajadores de la salud COMFANDI: Cali 1999-2000. S.C.T. 2001 - Vol. 4 (1) 20-28.
15. NGUYEN TRONG HIEU Safety and Immunogenicity of Recombinant Hepatitis B Vaccine. News of Medicine and Pharmacy. , 1996 - 10: 27-32.
16. PLOTKIN SA, ORENSTEIN WA (eds) “Vaccines” 2nd edition. Ed Saunders London 4 2001: 169.
17. MANDELL, Douglas and Bennets “Principles and practice of infectious diseases” 4th Ed Churchill N York 1995: 1429.
|
|
